Kinetics of Hepatitis B Surface Antigen Level in Chronic Hepatitis B Patients who Achieved Hepatitis B Surface Antigen Loss during Pegylated Interferon Alpha-2a Treatment

Background: Hepatitis B surface antigen (HBsAg) loss/seroconversion is considered to be the ideal endpoint of antiviral therapy and the ultimate treatment goal in chronic hepatitis B (CHB). This study aimed to assess the patterns of HBsAg kinetics in CHB patients who achieved HBsAg loss during the t...

Cijeli opis

Bibliografski detalji

Glavni autori:	Ming-Hui Li, Lu Zhang, Xiao-Jing Qu, Yao Lu, Ge Shen, Shu-Ling Wu, Min Chang, Ru-Yu Liu, Lei-Ping Hu, Zhen-Zhen Li, Wen-Hao Hua, Shu-Jing Song, Yao Xie
Format:	Artigo
Jezik:	Inglês
Izdano:	Wolters Kluwer 2017-01-01
Serija:	Chinese Medical Journal
Teme:	Chronic Hepatitis B; Hepatitis B Surface Antigen; Kinetics; Pegylated Interferon Alfa-2a
Online pristup:	http://www.cmj.org/article.asp?issn=0366-6999;year=2017;volume=130;issue=5;spage=559;epage=565;aulast=Li
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!